Company Analysis Shanghai Pharmaceuticals Holding Co., Ltd
1. Summary
Advantages
- Dividends (3.79%) are higher than the sector average (1.53%).
- The stock's return over the last year (-1.19%) is higher than the sector average (-10.48%).
Disadvantages
- Price (7.13 $) is higher than fair price (1.06 $)
- Current debt level 26.89% has increased over 5 years from 3.62%.
- The company's current efficiency (ROE=0.7745%) is lower than the sector average (ROE=13.27%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Shanghai Pharmaceuticals Holding Co., Ltd | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -10.9% | -3.9% |
| 90 days | -14.4% | -6.4% | -6% |
| 1 year | -1.2% | -10.5% | 5.2% |
SHPMY vs Sector: Shanghai Pharmaceuticals Holding Co., Ltd has outperformed the "Healthcare" sector by 9.29% over the past year.
SHPMY vs Market: Shanghai Pharmaceuticals Holding Co., Ltd has significantly underperformed the market by -6.35% over the past year.
Stable price: SHPMY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SHPMY with weekly volatility of -0.0229% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (7.13 $) is higher than the fair price (1.06 $).
Price is higher than fair: The current price (7.13 $) is 85.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (48.42) is higher than that of the sector as a whole (31.39).
P/E vs Market: The company's P/E (48.42) is lower than that of the market as a whole (53.25).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.3177) is lower than that of the sector as a whole (3.11).
P/BV vs Market: The company's P/BV (0.3177) is higher than that of the market as a whole (-8.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.703) is lower than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (0.703) is lower than that of the market as a whole (4.72).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (36.85) is higher than that of the sector as a whole (10.15).
EV/Ebitda vs Market: The company's EV/Ebitda (36.85) is higher than that of the market as a whole (28.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -17.36% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-17.36%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-27.73%).
5.4. ROE
ROE vs Sector: The company's ROE (0.7745%) is lower than that of the sector as a whole (13.27%).
ROE vs Market: The company's ROE (0.7745%) is lower than that of the market as a whole (4.93%).
5.5. ROA
ROA vs Sector: The company's ROA (0.2504%) is lower than that of the sector as a whole (6.22%).
ROA vs Market: The company's ROA (0.2504%) is lower than that of the market as a whole (16.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.06%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.79% is higher than the average for the sector '1.53%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.79% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 3.79% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (105.66%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
